Search Results - "Miyamura, Tomohiro"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Femoral bone mineral density as a tool of personalized medicine for rheumatoid arthritis: Interleukin-6 inhibitors for patients with low density whereas tumor necrosis factor inhibitor for patients with preserved density? by Takaoka, Hirokazu, Miyamura, Tomohiro, Shimada, Kota

    Published in SAGE open medicine (01-01-2024)
    “…There is a lack of indicators to distinguish between interleukin-6 inhibitors responders and tumor necrosis factor inhibitors responders in the treatment of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis by Furuta, Yoki, Miyamoto, Hideaki, Naoe, Hideaki, Shimoda, Miki, Hinokuma, Yukari, Miyamura, Tomohiro, Miyashita, Azusa, Fukushima, Satoshi, Tanaka, Motohiko, Sasaki, Yutaka

    Published in Case reports in gastroenterology (01-01-2020)
    “…Although most immune-related adverse events (irAEs) secondary to immune checkpoint inhibitors can be managed with immunosuppressive therapies; they can induce…”
    Get full text
    Journal Article
  5. 5

    An Autopsy Case of Metastatic Melanoma Originating from the Nasal Cavity That Was Treated With Nivolumab and Ipilimumab by Komohara, Yoshihiro, Miyamura, Tomohiro, Miyashita, Azusa, Shigeta, Hikaru, Nakagawa, Takenobu, Fukushima, Satoshi

    Published in Cancer diagnosis & prognosis (03-03-2021)
    “…Recent developments in antibodies targeting checkpoint molecules have improved the overall survival of patients with melanoma. A case of metastatic melanoma…”
    Get full text
    Journal Article
  6. 6

    An Autopsy Case of Metastatic Melanoma Originating from the Nasal Cavity That Was Treated With Nivolumab and Ipilimumab by Komohara, Yoshihiro, Miyamura, Tomohiro, Miyashita, Azusa, Shigeta, Hikaru, Nakagawa, Takenobu, Fukushima, Satoshi

    Published in Cancer diagnosis & prognosis (01-03-2021)
    “…BackgroundRecent developments in antibodies targeting checkpoint molecules have improved the overall survival of patients with melanoma. Case ReportA case of…”
    Get full text
    Report
  7. 7
  8. 8
  9. 9